X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-08-20 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $5.86 | -7,412 | 314,740 | -2% | -$43,437 | ||||||
| D | 2024-06-05 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale+OE | $7.12 | -145,000 | 322,152 | -31% | -$1,033,080 | |||||
2024-05-21 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $7.81 | -4,794 | 367,152 | -1% | -$37,446 | ||||||
| D | 2024-05-03 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale+OE | $8.35 | -39,949 | 370,189 | -10% | -$333,574 | |||||
2024-02-20 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $8.75 | -4,803 | 380,138 | -1% | -$42,008 | ||||||
2023-11-20 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $4.36 | -2,581 | 266,191 | -1% | -$11,259 | ||||||
2023-11-15 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $4.00 | -25,000 | 266,839 | -9% | -$99,998 | ||||||
2023-08-21 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $3.55 | -2,591 | 291,839 | -1% | -$9,203 | ||||||
2023-06-27 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $3.35 | -25,000 | 294,430 | -8% | -$83,633 | ||||||
2023-05-23 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $3.65 | -2,583 | 319,430 | -1% | -$9,436 | ||||||
2023-02-21 | ARDX | Williams Laura A | Chief Medical Officer | S - Sale | $3.00 | -3,187 | 319,013 | -1% | -$9,564 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |